## Abstract The absolute configuration of thiangazole (1), which was previously derived by chemical degradation, was confirmed by X‐ray structure analysis. Energy minimization with MO and MM2 methods indicate, that the conformation of 1 in the crystal is controlled by crystal forces while various e
Antibiotics from Gliding Bacteria, XLVII. Thiangazole: A Novel Inhibitor of HIV-1 fromPolyangium spec.
✍ Scribed by Jansen, Rolf ;Kunze, Brigitte ;Reichenbach, Hans ;Jurkiewicz, Elke ;Hunsmann, Gerhard ;Höfle, Gerhard
- Book ID
- 102365320
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 339 KB
- Volume
- 1992
- Category
- Article
- ISSN
- 0947-3440
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Using a biological screening with a HIV‐1/MT‐4 cell assay indicating antiviral activity and cell toxicity, we detected and isolated a new inhibiting metabolite from gliding bacteria, thiangazole (1). The structure of 1 was determined by spectroscopic methods to be a tris(thiazoline) derivative, showing a remarkable similarity to tantazole B (2). Chemical degradation and comparison with a synthetically prepared reference compound as well as with the degradation product from 2 furnished the (5__R__,8__S__,11__S__) configuration of the asymmetric centers in 1.
📜 SIMILAR VOLUMES
## Abstract Guided by a biological screening with a cell assay, the first HIV‐1 inhibitor from a gliding bacterium, phenoxan (1), was isolated. The structure of 1 was determined by spectroscopic methods to be a substituted oxazole‐γ‐pyrone, showing a remarkable similarity to aureothin (2) and spect
## Abstract From the myxobacterium __Sorangium cellulosum__, strain So ce26, a novel group of highly active antifungal metabolites was isolated. Large‐scale production of the basic compound soraphen A~1α~ (1) was achieved by fermentation in the presence of the adsorber resin XAD‐16, extraction and